High recovery rate nucleic acid extraction reagent

Shenzhen Uni-medica Nucleic Acid Extraction Reagent kit is adapted magnetic bead technology. 

The magnetic bead method for nucleic acid extraction has advantages that traditional DNA extraction methods can’t compare. It is mainly reflected in: 

① It can realize automation and large-scale operation.There are 96-well automatic nucleic acid extractors. The processing of 96 samples meets the high-throughput operating requirements of biology, enabling rapid and timely response to infectious disease outbreaks. This feature makes traditional methods unmatched; 

②Simple operation and short time, the entire extraction process has only four steps , Most of them can be completed within 36-40 minutes; 

③ safe and non-toxic, do not use toxic reagents such as benzene, chloroform in traditional methods, and reduce the harm to experimental operators to the minimum, which is fully in line with modern environmental protection concepts; 

④ magnetic beads and nucleic acid The specific binding makes the extracted nucleic acid have high purity and high concentration

This DNA RNA extraction reagent kit is suitable for virus nucleic acid isolation, nucleic acid purification，and accumulation of oropharyngeal swabs, nasopharyngeal swabs, saliva, serum, plasma, etc., for downstream PCR detection. All the nucleic acid extracting reagent and magnetic beads are preloaded in 96-deep–well plate.

Shenzhen Uni-medica nucleic acid purification reagent kit features not only easy and convenient operation, but also reliable and stable performance. it has been widely exported and used in more than 100 hospitals at home and abroad.

Shenzhen Uni-medica Technology Co., Ltd (Uni-medica) is a national high-tech enterprise. It has established cooperation and jointly performed a number of scientific research projects with the Hong Kong University of Science and Technology, Shenzhen University and Chinese Academy of Sciences. Uni-medica was also selected as one of the top 100 new Chinese innovative enterprises. The company takes the technical innovation of molecular detection methods as the core driving force, and focuses on the R&D and industrialization of molecular diagnostic products aiming at prevention and control of infectious diseases and genetic diseases. Uni-medica provides total solution of accurate diagnosis of infectious diseases and genetic diseases based on multi-omics technologies, including multiplex PCR, NGS technology and flow cytometry. Uni-medica is qualified by ISO 13485 and NMPA quality control system. The pathogen molecular detection products are daily used in hundreds of hospitals, Centers for Disease Control and Prevention and Quarantine Laboratories throughout the country, providing strong support for prevention and control of infectious diseases.